Cargando…
Penehyclidine hydrochloride: a potential drug for treating COPD by attenuating Toll-like receptors
BACKGROUND: The aim of this review was to evaluate and summarize the available scientific information on penehyclidine hydrochloride (PHC) for the treatment of chronic obstructive pulmonary disease (COPD) as a result of its ability to attenuate Toll-like receptors. Penehyclidine hydrochloride is an...
Autores principales: | Xiao, Hong-Tao, Liao, Zhi, Tong, Rong-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490683/ https://www.ncbi.nlm.nih.gov/pubmed/23139625 http://dx.doi.org/10.2147/DDDT.S36555 |
Ejemplares similares
-
Pleiotropic effects and pharmacological properties of penehyclidine hydrochloride
por: Wang, Yaguang, et al.
Publicado: (2018) -
Smoking Attenuates Efficacy of Penehyclidine Hydrochloride in Acute Respiratory Distress Syndrome Induced by Lipopolysaccharide in Rats
por: Zhao, Hongyan, et al.
Publicado: (2019) -
Neuroprotective effect of penehyclidine hydrochloride on focal cerebral ischemia-reperfusion injury★
por: Yu, Cuicui, et al.
Publicado: (2013) -
Postconditioning Protection Against Myocardiocyte Anoxia/Reoxygenation Injury From Penehyclidine Hydrochloride
por: Ren, JY, et al.
Publicado: (2019) -
Prevention of renal ischemia and reperfusion injury by penehyclidine hydrochloride through autophagy activation
por: Kang, Yuqing, et al.
Publicado: (2020)